Unique mechanism of action
CORDIART™ activates the production of Nitric Oxide (NO) by the endothelium, which in turn sends a signal to the vascular smooth muscles to relax. This induces vasodilatation of the blood vessels and supports a healthy circulation. More precisely, CORDIART™ stimulates eNOS activity and therefore helps to restore the physiological NO production.
Clinically studied action
CORDIART™ has shown in a randomized placebo controlled trial to significantly improve Flow Mediated Dilation (FMD), which is a direct marker of endothelial function. Three weeks of intervention resulted in a better response of the arteries to changes in blood flow. Subjects who received CORDIART™ showed a 20% higher FMD-score compared to subjects who received a placebo.